Kaupinen Wes bought PVLA
February 5, 2026 · Form 4 insider transaction
Kaupinen Wes bought 124,603 shares of Palvella Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
124,603
Price
$0.00
Total value
N/A
InsiderKaupinen Wes
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 5, 2026
Filing dateFebruary 9, 2026
Shares owned after124,603
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to this option shall vest and become exercisable in equal monthly installments over 48 months commencing from February 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.